Skip to main content Scroll Top

News

  • Home
  • Alzheimer
  • Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Most Viewed Posts
Clear Filters
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
7 February 2025
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
11 July 2019
Challenges in developing Geroscience trials
Challenges in developing Geroscience trials
19 August 2023
1 December 2022

Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation

15th Clinical Trials on Alzheimer’s Disease (CTAD) 2022, San Francisco
Read the article

Julien Delrieu, Aroa Relano-Gines, Patrice Cristofini, Julie Bisiaux, Sara Guillemin, Guillaume Blivet, Jacques Touchon

Share this article

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.